Update: 186 OctoberJuly 2023
TheWe callhave forpublished projectsa closednew onclarification 26question Julyalong 2023with andresponse.
Update: all28 applicationsJune have2023
We nowextended beenthe evaluated.
Tendeadline innovationfor projectssubmitting havebids beeninto selectedthe toMRIP receivecall aby proportion2 ofweeks theto funding.12pm on 26 July.
The Medical Radionuclide Innovation Programme (MRIP) is an up to £6 million R&D fund to support the development of technologies that could enable future access to medical radionuclides in the UK.
Up to £4 million has been allocated to the MRIP Innovation Project Workstream.Workstream, Thewhich MRIPis Innovationnow Projectopen fundingfor willapplications.
Eligibility
All supportapplications 10must projectsmeet acrossthe academiaeligibility andcriteria industry.set Theseout projectsin willthe deliverapplication innovativeguidance.
Clarifications
If researchyou intohave technologiesa andquestion techniqueson thatany couldaspect strengthenof the UK’sMRIP accessfund, toemail medicalMRIP@beis.gov.uk radionuclideswith in the future.
Findsubject outline more‘MRIP aboutRequest thefor successfulClarification’ projectsbefore 12 noon on 21 June 2023.
Eligibility
AllWe applicationswill mustpublish meethere theresponses eligibilityto criteriaall setmaterially outsignificant inquestions thereceived applicationduring guidance.this period on 28 June 2023.
How to apply
TheSubmit callyour forapplication projectsin closedfull as a zipped file to MRIP@beis.gov.uk by 12 noon on 26 July 2023.2023.
Title the email: ‘Application for MRIP Innovation Fund’ and include the name or the organisation(s) submitting the bid and a lead contact.
Contact us
If you have any questionsquestions, aboutcontact: the programme, email: mrip@energysecurity.gov.ukMRIP@beis.gov.uk.
Background
The Medical Radionuclide Innovation Programme was launched by the Chief Scientific Officer, Paul Monks, at a visit to the Hull Molecular Imaging Centre on the 8 December 2022.
The Programme will encourage innovation in technologies and techniques that could support access to radionuclides and increase our national resilience against global shortages.
It has been designed around 3 core workstreams:
1. Medical Radionuclide Landscape Assessment and Scenario Analysis - to build the evidence government requires to understand future supply and demand in the UK, informing future decisions on how to best safeguard the UK’s medical radionuclide supply.
- Phase 1, which included an assessment of the medical radionuclide landscape, concluded in May 2023
- Phase 2, which will focus on how future supply and demand could be forecasted, will commence later this financial year
2. Nuclear Material Access – DESNZ is working with the Nuclear Decommissioning Authority and their site licensedlicenced companies to better understand whether there are materials of value held within the UK Radioactive ‘Waste’ inventory and how accessible / useful they are for medical purposes.
3. Innovation Project Workstream – 10an innovationup projectsto are£4 beingmillion deliveredfund underto thissupport workstream.the development of technologies that could enable improved access to medical radionuclides in the future.
